AAAAAA

   
Results: 1-12 |
Results: 12
HOW DO CLINICIAN RESPOND TO PATIENTS WHO MISS APPOINTMENTS
Authors: SMOLLER JW MCLEAN RYS OTTO MW POLLACK MH
Citation: Jw. Smoller et al., HOW DO CLINICIAN RESPOND TO PATIENTS WHO MISS APPOINTMENTS, The Journal of clinical psychiatry, 59(6), 1998, pp. 330-338
A NEW STRATEGY FOR THE GENETIC-ANALYSIS OF ANXIOUS TEMPERAMENT
Authors: SMOLLER JW ROSENBAUM JF BIEDERMAN JB KAGAN J SUSSWEIN L HELBLING L SLAUGENHAUPT S
Citation: Jw. Smoller et al., A NEW STRATEGY FOR THE GENETIC-ANALYSIS OF ANXIOUS TEMPERAMENT, American journal of medical genetics, 81(6), 1998, pp. 488-488
SERTRALINE EFFECTS ON DYSPNEA IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE
Authors: SMOLLER JW POLLACK MH SYSTROM D KRADIN RL
Citation: Jw. Smoller et al., SERTRALINE EFFECTS ON DYSPNEA IN PATIENTS WITH OBSTRUCTIVE AIRWAYS DISEASE, Psychosomatics, 39(1), 1998, pp. 24-29
PANIC AND PHOBIC ANXIETY - DEFINING PHENOTYPES FOR GENETIC-STUDIES
Authors: SMOLLER JW TSUANG MT
Citation: Jw. Smoller et Mt. Tsuang, PANIC AND PHOBIC ANXIETY - DEFINING PHENOTYPES FOR GENETIC-STUDIES, The American journal of psychiatry, 155(9), 1998, pp. 1152-1162
INTERMITTENT LUTEAL-PHASE SERTRALINE TREATMENT OF DYSPHORIC PREMENSTRUAL-SYNDROME
Authors: HALBREICH U SMOLLER JW
Citation: U. Halbreich et Jw. Smoller, INTERMITTENT LUTEAL-PHASE SERTRALINE TREATMENT OF DYSPHORIC PREMENSTRUAL-SYNDROME, The Journal of clinical psychiatry, 58(9), 1997, pp. 399-402
INTERMITTENT LUTEAL-PHASE SERTRALINE TREATMENT OF DYSPHORIC PREMENSTRUAL-SYNDROME
Authors: SMOLLER JW HALBREICH U
Citation: Jw. Smoller et U. Halbreich, INTERMITTENT LUTEAL-PHASE SERTRALINE TREATMENT OF DYSPHORIC PREMENSTRUAL-SYNDROME, Biological psychiatry, 41, 1997, pp. 418-418
PANIC ANXIETY, DYSPNEA, AND RESPIRATORY-DISEASE - THEORETICAL AND CLINICAL CONSIDERATIONS
Authors: SMOLLER JW POLLACK MH OTTO MW ROSENBAUM JF KRADIN RL
Citation: Jw. Smoller et al., PANIC ANXIETY, DYSPNEA, AND RESPIRATORY-DISEASE - THEORETICAL AND CLINICAL CONSIDERATIONS, American journal of respiratory and critical care medicine, 154(1), 1996, pp. 6-17
VENLAFAXINE FOR PANIC DISORDER - RESULTS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: POLLACK MH WORTHINGTON JJ OTTO MW MAKI KM SMOLLER JW MANFRO GG RUDOLPH R ROSENBAUM JF
Citation: Mh. Pollack et al., VENLAFAXINE FOR PANIC DISORDER - RESULTS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Psychopharmacology bulletin, 32(4), 1996, pp. 667-670
DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VENLAFAXINE FOR PANIC DISORDER
Authors: POLLACK MH WORTHINGTON JJ OTTO MW SMOLLER JW MAKI KM RUDOLPH R ROSENBAUM JF
Citation: Mh. Pollack et al., DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VENLAFAXINE FOR PANIC DISORDER, Psychopharmacology bulletin, 32(3), 1996, pp. 496-496
SERTRALINE TREATMENT OF DYSPNEA IN PATIENTS WITH RESPIRATORY-DISEASE
Authors: SMOLLER JW POLLACK MH ROSENBAUM JF KRADIN R
Citation: Jw. Smoller et al., SERTRALINE TREATMENT OF DYSPNEA IN PATIENTS WITH RESPIRATORY-DISEASE, Psychopharmacology bulletin, 32(3), 1996, pp. 520-520
GENETIC-MAP OF RAT CHROMOSOME-5 INCLUDING THE FATTY (FA) LOCUS
Authors: TRUETT GE JACOB HJ MILLER J DROUIN G BAHARY N SMOLLER JW LANDER ES LEIBEL RL
Citation: Ge. Truett et al., GENETIC-MAP OF RAT CHROMOSOME-5 INCLUDING THE FATTY (FA) LOCUS, Mammalian genome, 6(1), 1995, pp. 25-30
THE LONGITUDINAL COURSE AND OUTCOME OF PANIC DISORDER
Authors: POLLACK MH SMOLLER JW
Citation: Mh. Pollack et Jw. Smoller, THE LONGITUDINAL COURSE AND OUTCOME OF PANIC DISORDER, The Psychiatric clinics of North America, 18(4), 1995, pp. 785
Risultati: 1-12 |